HomeCompareSRSA vs DIVO

SRSA vs DIVO: Dividend Comparison 2026

SRSA yields 19.90% · DIVO yields 6.49%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SRSA wins by $41.9K in total portfolio value
10 years
SRSA
SRSA
● Live price
19.90%
Share price
$10.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$72.6K
Annual income
$6,667.68
Full SRSA calculator →
DIVO
DIVO
● Live price
6.49%
Share price
$44.85
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$981.68
Full DIVO calculator →

Portfolio growth — SRSA vs DIVO

📍 SRSA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSRSADIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SRSA + DIVO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SRSA pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SRSA
Annual income on $10K today (after 15% tax)
$1,691.54/yr
After 10yr DRIP, annual income (after tax)
$5,667.53/yr
DIVO
Annual income on $10K today (after 15% tax)
$552.00/yr
After 10yr DRIP, annual income (after tax)
$834.43/yr
At 15% tax rate, SRSA beats the other by $4,833.10/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SRSA + DIVO for your $10,000?

SRSA: 50%DIVO: 50%
100% DIVO50/50100% SRSA
Portfolio after 10yr
$51.6K
Annual income
$3,824.68/yr
Blended yield
7.41%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SRSA buys
0
DIVO buys
0
No recent congressional trades found for SRSA or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSRSADIVO
Forward yield19.90%6.49%
Annual dividend / share$2.00$2.91
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$72.6K$30.7K
Annual income after 10y$6,667.68$981.68
Total dividends collected$41.2K$8.2K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: SRSA vs DIVO ($10,000, DRIP)

YearSRSA PortfolioSRSA Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$12,690$1,990.05$11,349$649.42+$1.3KSRSA
2$15,939$2,360.17$12,833$688.83+$3.1KSRSA
3$19,825$2,770.41$14,459$727.90+$5.4KSRSA
4$24,433$3,220.46$16,238$766.49+$8.2KSRSA
5$29,853$3,709.39$18,179$804.47+$11.7KSRSA
6$36,178$4,235.71$20,293$841.71+$15.9KSRSA
7$43,508$4,797.38$22,591$878.14+$20.9KSRSA
8$51,945$5,391.92$25,087$913.65+$26.9KSRSA
9$61,598$6,016.43$27,791$948.18+$33.8KSRSA
10$72,577$6,667.68$30,718$981.68+$41.9KSRSA

SRSA vs DIVO: Complete Analysis 2026

SRSAStock

Sarissa Capital Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify and acquire a business, which focuses on the healthcare and biopharmaceutical industry. Sarissa Capital Acquisition Corp. was incorporated in 2020 and is based in Greenwich, Connecticut.

Full SRSA Calculator →

DIVOETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this SRSA vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SRSA vs SCHDSRSA vs JEPISRSA vs OSRSA vs KOSRSA vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.